|
|
(763 גרסאות ביניים של 2 משתמשים אינן מוצגות) |
שורה 1: |
שורה 1: |
− | מפתח קודי ATC
| + | #הפניה [[t:קוד ATC code - ATC]] |
− | | |
− | | |
− | ==גישה מהירה [[#עוגןA|A]] / [[#עוגןB|B]] / [[#עוגןC|C]] / [[#עוגןD|D]] / [[#עוגןG|G]] / [[#עוגןH|H]] / [[#עוגןJ|J]] / [[#עוגןL|L]] / [[#עוגןM|M]] / [[#עוגןN|N]] / [[#עוגןP|P]] / [[#עוגןR|R]] / [[#עוגןS|S]] / [[#עוגןV|V]] ==
| |
− | | |
− | * הטבלא ניתנת למיון לפי כל אחת מהעמודות
| |
− | | |
− | {|border="1" dir="ltr" cellpadding="4" class="sortable"
| |
− | |1st level
| |
− | |2nd level
| |
− | |3rd level
| |
− | |4th level
| |
− | |5th level
| |
− | |Contents
| |
− | |-
| |
− | |{{עוגן2|עוגןA}}{{כ}}A
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Alimentary tract and metabolism]]
| |
− | |-
| |
− | |
| |
− | |A01
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Stomatological preparations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A01A
| |
− | |
| |
− | |
| |
− | |[[Stomatological preparations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AA
| |
− | |
| |
− | |[[Caries prophylactic agents]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AA01
| |
− | | [[Sodium fluoride]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AA02
| |
− | |[[Sodium monofluorophosphate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AA03
| |
− | |[[Olaflur]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AA04
| |
− | |[[Stannous fluoride]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AA30
| |
− | |[[Combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AA51
| |
− | |[[Sodium fluoride, combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AB
| |
− | |
| |
− | |[[Anti-infectives and antiseptics for local oral treatment]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AB02
| |
− | |[[Hydrogen peroxide]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AB03
| |
− | |[[Chlorhexidine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AB04
| |
− | |[[Amphotericin B]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AB05
| |
− | |[[Polynoxylin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AB06
| |
− | |[[Domiphen]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AB07
| |
− | |[[Oxyquinoline]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AB08
| |
− | |[[Neomycin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AB09
| |
− | |[[Miconazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AB10
| |
− | |[[Natamycin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AB11
| |
− | | [[Various]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AB12
| |
− | |[[Hexetidine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AB13
| |
− | |[[Tetracycline]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AB14
| |
− | | [[Benzoxonium chloride]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AB15
| |
− | | [[Tibezonium iodide]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AB16
| |
− | |[[Mepartricin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AB17
| |
− | |[[Metronidazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AB18
| |
− | | [[Clotrimazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AB19
| |
− | | [[Sodium perborate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AB21
| |
− | | [[Chlortetracycline]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AB22
| |
− | | [[Doxycycline]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AB23
| |
− | | [[Minocycline]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AC
| |
− | |
| |
− | | [[Corticosteroids for local oral treatment]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A01AC01
| |
− | | [[Triamcinolone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AC02
| |
− | | [[Dexamethasone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AC03
| |
− | | [[Hydrocortisone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AC54
| |
− | | [[Prednisolone, combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AD
| |
− | |
| |
− | |[[Other agents for local oral treatment]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AD01
| |
− | | [[Epinephrine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AD02
| |
− | | [[Benzydamine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AD05
| |
− | | [[Acetylsalicylic acid]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AD06
| |
− | | [[Adrenalone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AD07
| |
− | | [[Amlexanox]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AD08
| |
− | | [[Becaplermin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A01AD11
| |
− | | [[Various]]
| |
− | |-
| |
− | |
| |
− | |A02
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Drugs for acid related disorders]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A02A
| |
− | |
| |
− | |
| |
− | | [[Antacids]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02AA
| |
− | |
| |
− | | [[Magnesium compounds]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AA01
| |
− | | [[Magnesium carbonate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AA02
| |
− | | [[Magnesium oxide]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AA03
| |
− | | [[Magnesium peroxide]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AA04
| |
− | | [[Magnesium hydroxide]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AA05
| |
− | | [[Magnesium silicate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AA10
| |
− | | [[Combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02AB
| |
− | |
| |
− | | [[Aluminium compounds]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AB01
| |
− | | [[Aluminium hydroxide]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AB02
| |
− | | [[Algeldrate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AB03
| |
− | | [[Aluminium phosphate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AB04
| |
− | | [[Dihydroxialumini sodium carbonate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AB05
| |
− | | [[Aluminium acetoacetate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AB06
| |
− | | [[Aloglutamol]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AB07
| |
− | | [[Aluminium glycinate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AB10
| |
− | | [[Combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02AC
| |
− | |
| |
− | |[[Calcium compounds]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AC01
| |
− | | [[Calcium carbonate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02AC02
| |
− | | [[Calcium silicate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AC10
| |
− | | [[Combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02AD
| |
− | |
| |
− | | [[Combinations and complexes of aluminium, calcium and magnesium compounds]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02AD01
| |
− | | [[Ordinary salt combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AD02
| |
− | | [[Magaldrate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AD03
| |
− | | [[Almagate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AD04
| |
− | | [[Hydrotalcite]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AD05
| |
− | | [[Almasilate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02AF
| |
− | |
| |
− | | [[Antacids with antiflatulents]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AF01
| |
− | | [[Magaldrate and antiflatulents]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AF02
| |
− | | [[Ordinary salt combinations and antiflatulents]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02AG
| |
− | |
| |
− | | [[Antacids with antispasmodics]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | A02AH
| |
− | |
| |
− | | [[Antacids with sodium bicarbonate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02AX
| |
− | |
| |
− | | [[Antacids, other combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A02B
| |
− | |
| |
− | |
| |
− | | [[Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02BA
| |
− | |
| |
− | | [[H2-receptor antagonists]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02BA01
| |
− | | [[Cimetidine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BA02
| |
− | | [[Ranitidine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BA03
| |
− | | [[Famotidine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BA04
| |
− | | [[Nizatidine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BA05
| |
− | | [[Niperotidine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BA06
| |
− | | [[Roxatidine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BA07
| |
− | | [[Ranitidine bismuth citrate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BA08
| |
− | | [[Lafutidine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BA51
| |
− | | [[Cimetidine, combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BA53
| |
− | | [[Famotidine, combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02BB
| |
− | |
| |
− | | [[Prostaglandins]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BB01
| |
− | | [[Misoprostol]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BB02
| |
− | | [[Enprostil]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02BC
| |
− | |
| |
− | | [[Proton pump inhibitors]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BC01
| |
− | | [[Omeprazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BC02
| |
− | | [[Pantoprazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BC03
| |
− | | [[Lansoprazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BC04
| |
− | | [[Rabeprazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BC05
| |
− | | [[Esomeprazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BC06
| |
− | | [[Dexlansoprazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02BD
| |
− | |
| |
− | | [[Combinations for eradication of Helicobacter pylori]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BD01
| |
− | | [[Omeprazole, amoxicillin and metronidazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BD02
| |
− | | [[Lansoprazole, tetracycline and metronidazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BD03
| |
− | | [[Lansoprazole, amoxicillin and metronidazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BD04
| |
− | | [[Pantoprazole, amoxicillin and clarithromycin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BD05
| |
− | | [[Omeprazole, amoxicillin and clarithromycin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BD06
| |
− | | [[Esomeprazole, amoxicillin and clarithromycin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BD07
| |
− | | [[Lansoprazole, amoxicillin and clarithromycin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BD08
| |
− | | [[Bismuth subcitrate, tetracycline and metronidazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02BX
| |
− | |
| |
− | | [[Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX01
| |
− | | [[Carbenoxolone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX02
| |
− | | [[Sucralfate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX03
| |
− | | [[Pirenzepine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX04
| |
− | | [[Methiosulfonium chloride]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX05
| |
− | | [[Bismuth subcitrate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX06
| |
− | | [[Proglumide]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX07
| |
− | | [[Gefarnate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX08
| |
− | | [[Sulglicotide]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX09
| |
− | | [[Acetoxolone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX10
| |
− | | [[Zolimidine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX11
| |
− | | [[Troxipide]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX12
| |
− | | [[Bismuth subnitrate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX13
| |
− | | [[Alginic acid]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | A02BX51
| |
− | | [[Carbenoxolone, combinations excluding psycholeptics]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02BX71
| |
− | | [[Carbenoxolone, combinations with psycholeptics]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A02BX77
| |
− | | [[Gefarnate, combinations with psycholeptics]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A02X
| |
− | |
| |
− | |
| |
− | | [[Other drugs for acid related disorders]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |Empty
| |
− | |-
| |
− | |
| |
− | |A03
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Drugs for functional gastrointestinal disorders]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A03A
| |
− | |
| |
− | |
| |
− | |[[Drugs for functional gastrointestinal disorders]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AA
| |
− | |
| |
− | |[[Synthetic anticholinergics, esters with tertiary amino group]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AA01
| |
− | |[[Oxyphencyclimine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AA03
| |
− | |[[Camylofin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AA04
| |
− | |[[Mebeverine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AA05
| |
− | |[[Trimebutine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AA06
| |
− | |[[Rociverine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AA07
| |
− | |[[Dicycloverine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AA08
| |
− | |[[Dihexyverine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AA09
| |
− | |[[Difemerine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AA30
| |
− | |[[Piperidolate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AB
| |
− | |
| |
− | |[[Synthetic anticholinergics, quaternary ammonium compounds]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AC
| |
− | |
| |
− | |[[Synthetic antispasmodics, amides with tertiary amines]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AD
| |
− | |
| |
− | |[[Papaverine and derivatives]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AE
| |
− | |
| |
− | |[[Serotonin receptor antagonists]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A03AX
| |
− | |
| |
− | |[[Other drugs for functional gastrointestinal disorders]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A03B
| |
− | |
| |
− | |
| |
− | |[[Belladonna and derivatives, plain]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A03C
| |
− | |
| |
− | |
| |
− | |[[Antispasmodics in combination with psycholeptics]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A03D
| |
− | |
| |
− | |
| |
− | |[[Antispasmodics in combination with analgesics]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A03E
| |
− | |
| |
− | |
| |
− | |[[Antispasmodics and anticholinergics in combination with other drugs]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A03F
| |
− | |
| |
− | |
| |
− | |[[Propulsives]]
| |
− | |-
| |
− | |
| |
− | |A04
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antiemetics and antinauseants]]
| |
− | |-
| |
− | |
| |
− | |A05
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Bile and liver therapy]]
| |
− | |-
| |
− | |
| |
− | |A06
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Drugs for constipation]]
| |
− | |-
| |
− | |
| |
− | |A07
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antidiarrheals, intestinal anti-inflammatory/anti-infective agents]]
| |
− | |-
| |
− | |
| |
− | |A08
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antiobesity preparations, excluding diet products]]
| |
− | |-
| |
− | |
| |
− | |A09
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Digestives,including enzymes]]
| |
− | |-
| |
− | |
| |
− | |A10
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Drugs used in diabetes]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A10A
| |
− | |
| |
− | |
| |
− | |[[Insulins and analogues]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A10AB
| |
− | |
| |
− | |[[Insulins and analogues for injection, fast-acting]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A10AB01
| |
− | |[[Insulin (human)]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A10AB02
| |
− | [[Insulin (beef)]]
| |
− | ||A10AB03 Insulin (pork)
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A10AB04
| |
− | |[[Insulin lispro]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A10AB05
| |
− | [[Insulin aspart]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |A10AB06
| |
− | Insulin glulisine
| |
− | |A10AB30 Combinations
| |
− | |A10AC Insulins and analogues for injection, intermediate-acting
| |
− | |A10AC01 Insulin (human)
| |
− | |A10AC02 Insulin (beef)
| |
− | |A10AC03 Insulin (pork)
| |
− | |A10AC04 Insulin lispro
| |
− | |A10AC30 Combinations
| |
− | |A10AD Insulins and analogues for injection, intermediate-acting |combined with fast-acting
| |
− | |A10AD01 Insulin (human)
| |
− | |A10AD02 Insulin (beef)
| |
− | |A10AD03 Insulin (pork)
| |
− | |A10AD04 Insulin lispro
| |
− | |A10AD05 Insulin aspart
| |
− | |A10AD30 Combinations
| |
− | |A10AE Insulins and analogues for injection, long-acting
| |
− | |A10AE01 Insulin (human)
| |
− | |A10AE02 Insulin (beef)
| |
− | |A10AE03 Insulin (pork)
| |
− | |A10AE04 Insulin glargine
| |
− | |A10AE05 Insulin detemir
| |
− | |A10AE30 Combinations
| |
− | |A10AF Insulins and analogues for inhalation
| |
− | |A10AF01 Insulin (human)
| |
− | |A10B Blood glucose lowering drugs, excluding insulins
| |
− | | |
− | |A10BA Biguanides
| |
− | |A10BA01 Phenformin
| |
− | |A10BA02 Metformin
| |
− | |A10BA03 Buformin
| |
− | |A10BB Sulfonamides, urea derivatives
| |
− | |A10BB01 Glibenclamide
| |
− | |A10BB02 Chlorpropamide
| |
− | |A10BB03 Tolbutamide
| |
− | |A10BB04 Glibornuride
| |
− | |A10BB05 Tolazamide
| |
− | |A10BB06 Carbutamide
| |
− | |A10BB07 Glipizide
| |
− | |A10BB08 Gliquidone
| |
− | |A10BB09 Gliclazide
| |
− | |A10BB10 Metahexamide
| |
− | |A10BB11 Glisoxepide
| |
− | |A10BB12 Glimepiride
| |
− | |A10BB31 Acetohexamide
| |
− | |A10BC Sulfonamides (heterocyclic)
| |
− | |A10BC01 Glymidine
| |
− | |A10BD Combinations of oral blood glucose lowering drugs
| |
− | |A10BD01 Phenformin and sulfonamides
| |
− | |A10BD02 Metformin and sulfonamides
| |
− | |A10BD03 Metformin and rosiglitazone
| |
− | |A10BD04 Glimepiride and rosiglitazone
| |
− | |A10BD05 Metformin and pioglitazone
| |
− | |A10BD06 Glimepiride and pioglitazone
| |
− | |A10BD07 Metformin and sitagliptin
| |
− | |A10BD08 Metformin and vildagliptin
| |
− | |A10BD09 Pioglitazone and alogliptin
| |
− | |A10BD10 Metformin and saxagliptin
| |
− | |A10BD11 Metformin and linagliptin
| |
− | |A10BD12 Pioglitazone and sitagliptin
| |
− | |A10BD13 Metformin and alogliptin
| |
− | |A10BF Alpha glucosidase inhibitors
| |
− | |A10BF01 Acarbose
| |
− | |A10BF02 Miglitol
| |
− | |A10BF03 Voglibose
| |
− | |A10BG Thiazolidinediones
| |
− | |A10BG01 Troglitazone
| |
− | |A10BG02 Rosiglitazone
| |
− | |A10BG03 Pioglitazone
| |
− | |A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
| |
− | |A10BH01 Sitagliptin
| |
− | |A10BH02 Vildagliptin
| |
− | |A10BH03 Saxagliptin
| |
− | |A10BH04 Alogliptin
| |
− | |A10BH05 Linagliptin
| |
− | |A10BH51 Sitagliptin and simvastatin
| |
− | |A10BX Other blood glucose lowering drugs, excluding insulins
| |
− | |A10BX01 Guar gum
| |
− | |A10BX02 Repaglinide
| |
− | |A10BX03 Nateglinide
| |
− | |A10BX04 Exenatide
| |
− | |A10BX05 Pramlintide
| |
− | |A10BX06 Benfluorex
| |
− | |A10BX07 Liraglutide
| |
− | |A10BX08 Mitiglinide
| |
− | |A10BX09 Dapagliflozin
| |
− | |A10X Other drugs used in diabetes
| |
− | | |
− | |A10XA Aldose reductase inhibitors
| |
− | |A10XA01 Tolrestat
| |
− | | |
− | |-
| |
− | |
| |
− | |A11
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Vitamins]]
| |
− | |-
| |
− | |
| |
− | |A12
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Mineral supplements]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A12A
| |
− | |
| |
− | |
| |
− | |[[ֻCalcium]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A12B
| |
− | |
| |
− | |
| |
− | |[[Potassium]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |A12C
| |
− | |
| |
− | |
| |
− | |[[Other mineral supplements]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A12CA
| |
− | |
| |
− | |[[Sodium]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A12CB
| |
− | |
| |
− | |[[Zinc]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A12CC
| |
− | |
| |
− | |[[Magnesium]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A12CD
| |
− | |
| |
− | |[[Fluoride]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A12CE
| |
− | |
| |
− | |[[Selenium]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |A12CX
| |
− | |
| |
− | |[[Other mineral products]]
| |
− | |-
| |
− | |
| |
− | |A13
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Tonics]]
| |
− | |-
| |
− | |
| |
− | |A14
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Anabolic agents for systemic use]]
| |
− | |-
| |
− | |
| |
− | |A15
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Appetite stimulants]]
| |
− | |-
| |
− | |
| |
− | |A16
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Other alimentary tract and metabolism products]]
| |
− | |-
| |
− | |{{עוגן2|עוגןB}}{{כ}}B
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Blood and blood forming organs]]
| |
− | |-
| |
− | |
| |
− | |B01
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antithrombotic agents]]
| |
− | |-
| |
− | |
| |
− | |B02
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antihemorrhagics]]
| |
− | |-
| |
− | |
| |
− | |B03
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antianemic preparations]]
| |
− | |-
| |
− | |
| |
− | |B05
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Blood substitutes and perfusion solutions]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |B05A
| |
− | |
| |
− | |
| |
− | |[[Blood and related products]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AA
| |
− | |
| |
− | |[[Blood substitutes and plasma protein fractions]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AA01
| |
− | |[[Serum albumin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AA02
| |
− | |[[Other plasma protein fractions]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AA03
| |
− | |[[Fluorocarbon blood substitutes]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AA05
| |
− | |[[Dextran]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AA06
| |
− | |[[Gelatin agents]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AA07
| |
− | |[[Hydroxyethylstarch]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AA08
| |
− | |[[Hemoglobin crosfumaril]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AA09
| |
− | |[[Hemoglobin raffimer]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AA10
| |
− | |[[Hemoglobin glutamer (bovine)]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AX
| |
− | |
| |
− | |[[Other blood products]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AX01
| |
− | |[[Erythrocytes]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AX02
| |
− | |[[Thrombocytes]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AX03
| |
− | |[[Blood plasma]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05AX04
| |
− | |[[Stem cells from umbilical cord blood]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |B05B
| |
− | |
| |
− | |
| |
− | |[[I.v. solutions]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BA
| |
− | |
| |
− | |[[Solutions for parenteral nutrition]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BA01
| |
− | |[[Amino acids]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BA02
| |
− | |[[Fat emulsions]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BA03
| |
− | |[[Carbohydrates]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BA04
| |
− | |[[Protein hydrolysates]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BA10
| |
− | |[[Combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BB
| |
− | |
| |
− | |[[Solutions affecting the electrolyte balance]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BB01
| |
− | |[[Electrolytes]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BB02
| |
− | |[[Electrolytes with carbohydrates]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BB03
| |
− | |[[Trometamol]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BB04
| |
− | |[[Electrolytes in combination with other drugs]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BC
| |
− | |
| |
− | |[[Solutions producing osmotic diuresis]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BC01
| |
− | |[[Mannitol]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05BC02
| |
− | |[[Carbamide]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |B05C
| |
− | |
| |
− | |
| |
− | |[[Irrigating solutions]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CA
| |
− | |
| |
− | |[[Antiinfectives]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CA01
| |
− | |[[Cetylpyridinium]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CA02
| |
− | |[[Chlorhexidine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CA03
| |
− | |[[Nitrofural]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CA04
| |
− | |[[Sulfamethizole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CA05
| |
− | |[[Taurolidine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CA06
| |
− | |[[Mandelic acid]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CA07
| |
− | |[[Noxytiolin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CA08
| |
− | |[[Ethacridine lactate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CA09
| |
− | |[[Neomycin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CA10
| |
− | |[[Combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CB
| |
− | |
| |
− | |[[Salt solutions]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CB01
| |
− | |[[Sodium chloride]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CB02
| |
− | |[[Sodium citrate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CB03
| |
− | |[[Magnesium citrate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CB04
| |
− | |[[Sodium bicarbonate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CB10
| |
− | |[[Combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CX
| |
− | |
| |
− | |[[Other irrigating solutions]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CX01
| |
− | |[[Glucose]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CX02
| |
− | |[[Sorbitol]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CX03
| |
− | |[[Glycine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CX04
| |
− | |[[Mannitol]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05CX10
| |
− | |[[Combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |B05D
| |
− | |
| |
− | |
| |
− | |[[Peritoneal dialytics]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05DA
| |
− | |
| |
− | |[[Isotonic solutions]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05DB
| |
− | |
| |
− | |[[Hypertonic solutions]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |B05X
| |
− | |
| |
− | |
| |
− | |[[I.v. solution additives]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA
| |
− | |
| |
− | |[[Electrolyte solutions]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA01
| |
− | |[[Potassium chloride]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA02
| |
− | |[[Sodium bicarbonate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA03
| |
− | |[[Sodium chloride]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA04
| |
− | |[[Ammonium chloride]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA05
| |
− | |[[Magnesium sulfate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA06
| |
− | |[[Potassium phosphate]], including combinations with other potassium salts
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA07
| |
− | |[[Calcium chloride]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA08
| |
− | |[[Sodium acetate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA09
| |
− | |[[Sodium phosphate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA10
| |
− | |[[Magnesium phosphate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA11
| |
− | |[[Magnesium chloride]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA12
| |
− | |[[Zinc chloride]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA13
| |
− | |[[Hydrochloric acid]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA14
| |
− | |[[Sodium glycerophosphate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA15
| |
− | |[[Potassium lactate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA16
| |
− | |[[Cardioplegia solutions]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA17
| |
− | |[[Potassium acetate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA30
| |
− | |[[Combinations of electrolytes]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XA31
| |
− | |[[Electrolytes in combination with other drugs]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XB
| |
− | |
| |
− | |[[Amino acids]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XB01
| |
− | |[[Arginine hydrochloride]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XB02
| |
− | |[[Alanyl glutamine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XB03
| |
− | |[[Lysine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XC
| |
− | |
| |
− | |[[Vitamins]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XX
| |
− | |
| |
− | |[[Other i.v. solution additives]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05XX02
| |
− | |[[Trometamol]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |B05Z
| |
− | |
| |
− | |
| |
− | |[[Hemodialytics and hemofiltrates]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05ZA
| |
− | |
| |
− | |[[Hemodialytics, concentrates]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |B05ZB
| |
− | |
| |
− | |[[Hemofiltrates]]
| |
− | |-
| |
− | |
| |
− | |B06
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Other hematological agents]]
| |
− | |-
| |
− | |{{עוגן2|עוגןC}}{{כ}}C
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Cardiovascular system]]
| |
− | |-
| |
− | |
| |
− | |C01
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Cardiac therapy]]
| |
− | |-
| |
− | |
| |
− | |C02
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antihypertensives]]
| |
− | |-
| |
− | |
| |
− | |C03
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Diuretics]]
| |
− | |-
| |
− | |
| |
− | |C04
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Peripheral vasodilators]]
| |
− | |-
| |
− | |
| |
− | |C05
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Vasoprotectives]]
| |
− | |-
| |
− | |
| |
− | |C07
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Beta blocking agents]]
| |
− | |-
| |
− | |
| |
− | |C08
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Calcium channel blockers]]
| |
− | |-
| |
− | |
| |
− | |C09
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Agents acting on the renin-angiotensin system]]
| |
− | |-
| |
− | |
| |
− | |C10
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Lipid modifying agents]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |C10A
| |
− | |
| |
− | |
| |
− | |[[Lipid modifying agents, plain]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |C10AA
| |
− | |
| |
− | |[[HMG CoA reductase inhibitors]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |C10AB
| |
− | |
| |
− | |[[Fibrates]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |C10AC
| |
− | |
| |
− | |[[Bile acid sequestrants]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | C10AC01
| |
− | |[[Colestyramine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |C10AC02
| |
− | |[[Colestipol]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | C10AC03
| |
− | |[[Colextran]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |C10AC04
| |
− | |[[Colesevelam]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |C10AD
| |
− | |
| |
− | |[[Nicotinic acid and derivatives]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |C10AX
| |
− | |
| |
− | |[[Other lipid modifying agents]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |C10B
| |
− | |
| |
− | |
| |
− | |[[Lipid modifying agents, combinations]]
| |
− | |-
| |
− | |{{עוגן2|עוגןD}}{{כ}}D
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Dermatologicals]]
| |
− | |-
| |
− | |
| |
− | |D01
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antifungals for dermatological use]]
| |
− | |-
| |
− | |
| |
− | |D02
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Emollients and protectives]]
| |
− | |-
| |
− | |
| |
− | |D03
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Preparations for treatment of wounds and ulcers]]
| |
− | |-
| |
− | |
| |
− | |D04
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antipruritics, including antihistamines, anesthetics, etc]]
| |
− | |-
| |
− | |
| |
− | |D05
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antipsoriatics]]
| |
− | |-
| |
− | |
| |
− | |D06
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antibiotics and chemotherapeutics for dermatological use]]
| |
− | |-
| |
− | |
| |
− | |D07
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Corticosteroids, dermatological preparations]]
| |
− | |-
| |
− | |
| |
− | |D08
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antiseptics and disinfectants]]
| |
− | |-
| |
− | |
| |
− | |D09
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Medicated dressings]]
| |
− | |-
| |
− | |
| |
− | |D10
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Anti-acne preparations]]
| |
− | |-
| |
− | |
| |
− | |D11
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Other dermatological preparations]]
| |
− | |-
| |
− | |{{עוגן2|עוגןG}}{{כ}}G
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Genito-urinary system and sex hormones]]
| |
− | |-
| |
− | |
| |
− | |G01
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Gynecological antiinfectives and antiseptics]]
| |
− | |-
| |
− | |
| |
− | |G02
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Other gynecologicals]]
| |
− | |-
| |
− | |
| |
− | |G03
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Sex hormones and modulators of the genital system]]
| |
− | |-
| |
− | |
| |
− | |G04
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Urologicals]]
| |
− | |-
| |
− | |{{עוגן2|עוגןH}}{{כ}}H
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Systemic hormonal preparations, excluding sex hormones and insulins]]
| |
− | |-
| |
− | |
| |
− | |H01
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Pituitary and hypothalamic hormones and analogues]]
| |
− | |-
| |
− | |
| |
− | |H02
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Corticosteroids for systemic use]]
| |
− | |-
| |
− | |
| |
− | |H03
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Thyroid therapy]]
| |
− | |-
| |
− | |
| |
− | |H04
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Pancreatic hormones]]
| |
− | |-
| |
− | |
| |
− | |H05
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Calcium homeostasis]]
| |
− | |-
| |
− | |{{עוגן2|עוגןJ}}{{כ}}J
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antiinfectives for systemic use]]
| |
− | |-
| |
− | |
| |
− | |J01
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antibacterials for systemic use]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |J01A
| |
− | |
| |
− | |
| |
− | |[[Tetracyclines]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |J01B
| |
− | |
| |
− | |
| |
− | |[[Amphenicols]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |J01C
| |
− | |
| |
− | |
| |
− | |[[Beta-lactam antibacterials, penicillins]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |J01D
| |
− | |
| |
− | |
| |
− | |[[Other beta-lactam antibacterials]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |J01E
| |
− | |
| |
− | |
| |
− | |[[Sulfonamides and trimethoprim]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |J01F
| |
− | |
| |
− | |
| |
− | |[[Macrolides, lincosamides and streptogramins]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |J01G
| |
− | |
| |
− | |
| |
− | |[[Aminoglycoside antibacterials]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |J01M
| |
− | |
| |
− | |
| |
− | |[[Quinolone antibacterials]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |J01R
| |
− | |
| |
− | |
| |
− | |[[Combinations of antibacterials]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |J01X
| |
− | |
| |
− | |
| |
− | |[[Other antibacterials]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J01XA
| |
− | |
| |
− | |[[Glycopeptide antibacterials]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J01XB
| |
− | |
| |
− | |[[Polymyxins]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J01XC
| |
− | |
| |
− | |[[Steroid antibacterials]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J01XD
| |
− | |
| |
− | |[[Imidazole derivatives]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J01XE
| |
− | |
| |
− | |[[Nitrofuran derivatives]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | | J01XX
| |
− | |
| |
− | |[[Other antibacterials]]
| |
− | |-
| |
− | |
| |
− | |J02
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antimycotics for systemic use]]
| |
− | |-
| |
− | |
| |
− | |J04
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antimycobacterials]]
| |
− | |-
| |
− | |
| |
− | |J05
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antivirals for systemic use]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |J05A
| |
− | |
| |
− | |
| |
− | |[[Direct acting antiviral drugs]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AA
| |
− | |
| |
− | |[[Thiosemicarbazones]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AB
| |
− | |
| |
− | |[[Nucleosides and nucleotides excluding reverse transcriptase inhibitors]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AC
| |
− | |
| |
− | |[[Cyclic amines]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AD
| |
− | |
| |
− | |[[Phosphonic acid derivatives]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AE
| |
− | |
| |
− | |[[Protease inhibitors]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AF
| |
− | |
| |
− | |[[Nucleoside and nucleotide reverse transcriptase inhibitors]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AF01
| |
− | | [[Zidovudine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AF02
| |
− | | [[Didanosine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AF03
| |
− | | [[Zalcitabine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AF04
| |
− | | [[Stavudine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AF05
| |
− | | [[Lamivudine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AF06
| |
− | | [[Abacavir]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AF07
| |
− | | Tenofovir [[disoproxil]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AF08
| |
− | | Adefovir [[dipivoxil]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AF09
| |
− | | [[Emtricitabine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AF10
| |
− | | [[Entecavir]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AF11
| |
− | | [[Telbivudine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AF12
| |
− | | [[Clevudine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AG
| |
− | |
| |
− | |[[Non-nucleoside reverse transcriptase inhibitors]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AG01
| |
− | |[[Nevirapine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AG02
| |
− | |[[Delavirdine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AG03
| |
− | |[[Efavirenz]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AG04
| |
− | |[[Etravirine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AG05
| |
− | |[[Rilpivirine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AH
| |
− | |
| |
− | |[[Neuraminidase inhibitors]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AR
| |
− | |
| |
− | |[[Antivirals for treatment of HIV infections, combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J05AX
| |
− | |
| |
− | |[[Other antivirals]]
| |
− | |-
| |
− | |
| |
− | |J06
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Immune sera and immunoglobulins]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |J06A
| |
− | |
| |
− | |
| |
− | | [[Immune sera]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06AA
| |
− | |
| |
− | | [[Immune sera]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06AA01
| |
− | | [[Diphtheria antitoxin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | J06AA02
| |
− | | [[Tetanus antitoxin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06AA03
| |
− | | [[Snake venom antiserum]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | J06AA04
| |
− | | [[Botulinum antitoxin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06AA05
| |
− | | [[Gas-gangrene sera]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | J06AA06
| |
− | | [[Rabies serum]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |J06B
| |
− | |
| |
− | |
| |
− | | [[Immunoglobulins]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BA
| |
− | |
| |
− | |[[Immunoglobulins, normal human]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BA01
| |
− | |[[Immunoglobulins, normal human, for extravascular administration]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | J06BA02
| |
− | |[[Immunoglobulins, normal human, for intravascular administration]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB
| |
− | |
| |
− | |[[Specific immunoglobulins]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB01
| |
− | |[[Anti-D (rh) immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB02
| |
− | | [[Tetanus immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB03
| |
− | | [[Varicella/zoster immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB04
| |
− | | [[Hepatitis B immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB05
| |
− | | [[Rabies immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | J06BB06
| |
− | | [[Rubella immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | J06BB07
| |
− | | [[Vaccinia immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB08
| |
− | | [[Staphylococcus immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | J06BB09
| |
− | | [[Cytomegalovirus immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB10
| |
− | | [[Diphtheria immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB11
| |
− | | [[Hepatitis A immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB12
| |
− | | [[Encephalitis, tick borne immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB13
| |
− | | [[Pertussis immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB14
| |
− | |[[Morbilli immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB15
| |
− | | [[Parotitis immunoglobulin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB16
| |
− | | [[Palivizumab]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | J06BB17
| |
− | | [[Motavizumab]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BB30
| |
− | | [[Combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BC
| |
− | |
| |
− | | [[Other immunoglobulins]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |J06BC01
| |
− | | [[Nebacumab]]
| |
− | |-
| |
− | |{{עוגן2|עוגןL}}{{כ}}L
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antineoplastic and immunomodulating agents]]
| |
− | |-
| |
− | |
| |
− | |L01
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antineoplastic agents]]
| |
− | |-
| |
− | |
| |
− | |L02
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Endocrine therapy]]
| |
− | |-
| |
− | |
| |
− | |L03
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Immunostimulants]]
| |
− | |-
| |
− | |
| |
− | |L04
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Immunosuppressants]]
| |
− | |-
| |
− | |{{עוגן2|עוגןM}}{{כ}}M
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Musculo-skeletal system]]
| |
− | |-
| |
− | |
| |
− | |M01
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Anti-inflammatory and antirheumatic products]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |M01A
| |
− | |
| |
− | |
| |
− | |[[Anti-inflammatory and antirheumatic products, non-steroids]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |M01AA
| |
− | |
| |
− | |[[Butylpyrazolidines]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |M01AB
| |
− | |
| |
− | |[[Acetic acid derivatives and related substances]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB01
| |
− | | [[Indometacin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB02
| |
− | | [[Sulindac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB03
| |
− | | [[Tolmetin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB04
| |
− | | [[Zomepirac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB05
| |
− | | [[Diclofenac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB06
| |
− | | [[Alclofenac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB07
| |
− | | [[Bumadizone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB08
| |
− | | [[Etodolac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB09
| |
− | | [[Lonazolac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB10
| |
− | | [[Fentiazac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB11
| |
− | | [[Acemetacin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB12
| |
− | | [[Difenpiramide]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB13
| |
− | | [[Oxametacin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB14
| |
− | | [[Proglumetacin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB15
| |
− | | [[Ketorolac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB16
| |
− | | [[Aceclofenac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB17
| |
− | | [[Bufexamac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB51
| |
− | | [[Indometacin, combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | M01AB55
| |
− | | [[Diclofenac, combinations]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |M01AC
| |
− | |
| |
− | |[[Oxicams]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |M01AE
| |
− | |
| |
− | |[[Propionic acid derivatives]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |M01AG
| |
− | |
| |
− | |[[Fenamates]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |M01AH
| |
− | |
| |
− | |[[Coxibs]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |M01AX
| |
− | |
| |
− | |[[Other anti-inflammatory and antirheumatic agents, non-steroids]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |M01B
| |
− | |
| |
− | |
| |
− | |[[Anti-inflammatory/antirheumatic agents in combination]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |M01C
| |
− | |
| |
− | |
| |
− | |[[Specific antirheumatic agents]]
| |
− | |-
| |
− | |
| |
− | |M02
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Topical products for joint and muscular pain]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |M02A
| |
− | |
| |
− | |
| |
− | |[[Topical products for joint and muscular pain]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA
| |
− | |
| |
− | |[[Anti-inflammatory preparations, non-steroids for topical use]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA01
| |
− | |[[Phenylbutazone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA02
| |
− | |[[Mofebutazone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA03
| |
− | |[[Clofezone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA04
| |
− | |[[Oxyphenbutazone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA05
| |
− | |[[Benzydamine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA06
| |
− | |[[Etofenamate]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA07
| |
− | |[[Piroxicam]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA08
| |
− | |[[Felbinac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA09
| |
− | |[[Bufexamac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA10
| |
− | |[[Ketoprofen]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA11
| |
− | |[[Bendazac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA12
| |
− | |[[Naproxen]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA13
| |
− | |[[Ibuprofen]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA14
| |
− | |[[Fentiazac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA15
| |
− | |[[Diclofenac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA16
| |
− | |[[Feprazone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA17
| |
− | |[[Niflumic acid]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA18
| |
− | |[[Meclofenamic acid]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA19
| |
− | |[[Flurbiprofen]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA21
| |
− | |[[Tolmetin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA22
| |
− | |[[Suxibuzone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA23
| |
− | |[[Indometacin]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA24
| |
− | |[[Nifenazone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA25
| |
− | |[[Aceclofenac]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AA26
| |
− | |[[Nimesulide]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AB
| |
− | |
| |
− | |[[Capsaicin and similar agents]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AC
| |
− | |
| |
− | |[[Preparations with salicylic acid derivatives]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |M02AX
| |
− | |
| |
− | |[[Other topical products for joint and muscular pain]]
| |
− | |-
| |
− | |
| |
− | |M03
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Muscle relaxants]]
| |
− | |-
| |
− | |
| |
− | |M04
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antigout preparations]]
| |
− | |-
| |
− | |
| |
− | |M05
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Drugs for treatment of bone diseases]]
| |
− | |-
| |
− | |
| |
− | |M09
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Other drugs for disorders of the musculo-skeletal system]]
| |
− | |-
| |
− | |{{עוגן2|עוגןN}}{{כ}}N
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Nervous system]]
| |
− | |-
| |
− | |
| |
− | |N01
| |
− | |
| |
− | |
| |
− | |
| |
− | | [[Anesthetics]]
| |
− | |-
| |
− | |
| |
− | |N02
| |
− | |
| |
− | |
| |
− | |
| |
− | | [[Analgesics]]
| |
− | |-
| |
− | |
| |
− | |N03
| |
− | |
| |
− | |
| |
− | |
| |
− | | [[Antiepileptics]]
| |
− | |-
| |
− | |
| |
− | |N04
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Anti-parkinson drugs]]
| |
− | |-
| |
− | |
| |
− | |N05
| |
− | |
| |
− | |
| |
− | |
| |
− | | [[Psycholeptics]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |N05A
| |
− | |
| |
− | |
| |
− | | [[Antipsychotics]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AA
| |
− | |
| |
− | |[[Phenothiazines with aliphatic side-chain]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AB
| |
− | |
| |
− | |[[Phenothiazines with piperazine structure]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AC
| |
− | |
| |
− | |[[Phenothiazines with piperidine structure]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AD
| |
− | |
| |
− | |[[Butyrophenone derivatives]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AE
| |
− | |
| |
− | |[[Indole derivatives]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AF
| |
− | |
| |
− | |[[Thioxanthene derivative]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AG
| |
− | |
| |
− | |[[Diphenylbutylpiperidine derivatives]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AH
| |
− | |
| |
− | |[[Diazepines, oxazepines, thiazepines and oxepines]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AL
| |
− | |
| |
− | |[[Benzamides]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AN
| |
− | |
| |
− | |[[Lithium]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AX
| |
− | |
| |
− | |[[Other antipsychotics]]
| |
− | |-
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | | N05AX07
| |
− | |[[Prothipendyl]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AX08
| |
− | |[[Risperidone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AX10
| |
− | |[[Mosapramine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AX11
| |
− | |[[Zotepine]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AX12
| |
− | |[[Aripiprazole]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AX13
| |
− | |[[Paliperidone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |N05AX14
| |
− | |[[Iloperidone]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |N05B
| |
− | |
| |
− | |
| |
− | | [[Anxiolytics]]
| |
− | |-
| |
− | |
| |
− | |
| |
− | |N05C
| |
− | |
| |
− | |
| |
− | | [[Hypnotics and sedatives]]
| |
− | |-
| |
− | |
| |
− | |N06
| |
− | |
| |
− | |
| |
− | |
| |
− | | [[Psychoanaleptics]]
| |
− | |-
| |
− | |
| |
− | |N07
| |
− | |
| |
− | |
| |
− | |
| |
− | | [[Other nervous system drugs]]
| |
− | |-
| |
− | |{{עוגן2|עוגןP}}{{כ}}P
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antiparasitic products, insecticides and repellents]]
| |
− | |-
| |
− | |
| |
− | |P01
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antiprotozoals]]
| |
− | |-
| |
− | |
| |
− | |P02
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Anthelmintics]]
| |
− | |-
| |
− | |
| |
− | |P03
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Ectoparasiticides, including scabicides, insecticides and repellents]]
| |
− | |-
| |
− | |{{עוגן2|עוגןR}}{{כ}}R
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Respiratory system]]
| |
− | |-
| |
− | |
| |
− | |R01
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Nasal preparations]]
| |
− | |-
| |
− | |
| |
− | |R02
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Throat preparations]]
| |
− | |-
| |
− | |
| |
− | |R03
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Drugs for obstructive airway diseases]]
| |
− | |-
| |
− | |
| |
− | |R05
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Cough and cold preparations]]
| |
− | |-
| |
− | |
| |
− | |R06
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Antihistamines for systemic use]]
| |
− | |-
| |
− | |
| |
− | |R07
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Other respiratory system products]]
| |
− | |-
| |
− | |{{עוגן2|עוגןS}}{{כ}}S
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Sensory organs]]
| |
− | |-
| |
− | |
| |
− | |S01
| |
− | |
| |
− | |
| |
− | |
| |
− | | [[Ophthalmologicals]]
| |
− | |-
| |
− | |
| |
− | |S02
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Otologicals]]
| |
− | |-
| |
− | |
| |
− | |S03
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Ophthalmological and otological preparations]]
| |
− | |-
| |
− | |{{עוגן2|עוגןV}}{{כ}}V
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Various]]
| |
− | |-
| |
− | |
| |
− | |V01
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Allergens]]
| |
− | |-
| |
− | |
| |
− | |V03
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[All other therapeutic products]]
| |
− | |-
| |
− | |
| |
− | |V04
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Diagnostic agents]]
| |
− | |-
| |
− | |
| |
− | |V06
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[General nutrients]]
| |
− | |-
| |
− | |
| |
− | |V07
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[All other non-therapeutic products]]
| |
− | |-
| |
− | |
| |
− | |V08
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Contrast media]]
| |
− | |-
| |
− | |
| |
− | |V09
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Diagnostic radiopharmaceuticals]]
| |
− | |-
| |
− | |
| |
− | |V10
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Therapeutic radiopharmaceuticals]]
| |
− | |-
| |
− | |
| |
− | |V20
| |
− | |
| |
− | |
| |
− | |
| |
− | |[[Surgical dressings]]
| |
− | |}
| |
− | | |
− | ==ביבליוגרפיה==
| |
− | | |
− | * [http://www.whocc.no/atc_ddd_index/ ATC/DDD Index 2013]
| |
− | | |
− | [[קטגוריה:Anatomical Therapeutic Chemical (ATC) classification]]
| |